1.GORINI S,GATTA L,PONTECORVOL,et al.Regulationof innate immunity by extracellular Nucleotides[J].Am JBlood Res,2013,3(1):14-28.

2.ZIMME R MANN H.Extracellular ATP and othernucleotides-ubiquitous triggers of intercellular messenger release[J].PurinergicSignal,2016,12(1):25-57.DOI:10.1007/s11302-015-9483-2.

3.DOU L,CHEN Y F,COWAN PJ,et al.ExtracellularATP signaling and clinical relevance[J].J ClinImmunol,2017,188:67-73.DOI:10.1016/j.clim.2017.12.006.

4.JACOB F,NOVO C P,BACHERTC,et al.Purinergicsignaling in inflammatory cells:P2 receptor expression,functionaleffects,and modulation of inflammatory responses[J].PurinergicSignal,2013,9(3):285-306.DOI:10.1007/s11302-013-9357-4.

5.HAＲADAY,KATO Y,MIYAJI T,et al.Vesicular nucleotide transporter mediates ATP releaseand migration in neutrophils[J].JBC,2018,293(10):3770-3779.DOI: 10.1074/jbc.M117.810168.

6.FAAS M M,SAEZ T,DEVOS P.ExtracellularATP and adenosine:The Yin and Yang in immune responses[J].MolAspects Med,2017,55:9-19.DOI:10.1016/j.mam.2017.01.002.

7.TAKENAKA M C,ＲOBSON S,QUINTANAF J.Ｒegulation of the T cellresponse by CD39[J].TrendsImmunol,2016,37(7):427-439.DOI:1.1016/j.it.2016.04.009.

8.REBECCA C COLL,AVRIL A B ＲOBEＲTSON,JAE JINCHAE,et al.Asmall-molecule inhibitor of the NLRP3 inflammasome forthetreatment of inflammatory diseases[J].NatMed,2015,21(3):248-255.DOI:10.1038/nm.3806.

9.The NALP3 inflammasome is involved in neurotoxic prionpeptideinduced microglial activation[J]. JNeuroinflamm,2012,9(1):73.DOI:10.1186/1742-2094-9-73.

10.SOLLE M,LABASI J,PEＲＲEGAUX D G,et al.Altered cytokine production in mice lacking P2X7receptors[J].JBC,2001,276(1):125-132.DOI:10.1074/jbc.M006781200.

11.GORELENKOVA MILLER O,MIEYALJ J. Sulfhydryl-mediated redox signaling in inflammation: role inneurodegenerative diseases[J].ArchToxicol,2015,89 (9):1439-1467.DOI:10.1007/s00204-015-1496-7.

12.KAUFMANN A,MUSSET B,LIMBERGS H,et al.Hosttissue

Damage signal ATPpromotes non-directional migration and negatively regulates Toll-like receptorsignaling in human monocytes[J].JBC,2005,280(37):32459-32467.DOI:10.1074/jbc.M505301200.

13.MARQUES-DA-SILVA C,BURNSTOCKG,OJCIUS D M,et al.Purinergic receptor agonists modulate phagocytosis andclearance of apoptotic cells in macrophages[J].Immunobiology,2011,216(1-2):1-11.DOI:10.1016/j.imbio.2010.03.010.

14.VIRGILIO F D. Purinergic mechanism in the immune system:A signalof danger for dendritic cells[J].PurinergicSignal,2005,1(3):205-209.DOI:10.1007/s11302-005-6312-z.

15.CEKIC C,LINDEN J.Purinergicregulation of the immune system[J].Nat RevImmunol,2016,16(3):177-192.DOI:10.1038/nri.2016.4.

16.IVISON S M,HIMMEL M E,MAYER M,et al.The Stress signal extracellular ATP modulatesantiflagellin immune responses in intestinal epithelial cells[J].InflammBowel Dis,2011,17(1):319-333.DOI:10.1002/ibd.21428.

17.KELLY D,DELDAY M I,MULDERI. Microbes and microbial effector molecules in treatment of inflammatorydisorders[J].Immunol Rev,2015,245(1):27-44.DOI:10.1111/j.1600-065X.2011.01079.x.

18.XU P,FENG X,LUAN H,et al.Current knowledge on the nucleotide agonists for theP2Y2 recepto[J].Bioorg Med Chem,2018,26(2):366-375.DOI:10.1016/j.bmc.2017.11.043.

19.IDZKO M,FERRARI D,ELTZSCHIGH K. Nucleotide signalling during inflammation[J].Nature,2014,509 (7500):310-317.DOI:10.1038/nature13085.

20.BRAGANHOL E,KUKULSKI F,LVESQUES A,et al.Nucleotidereceptors control IL-8/CXCL8 and MCP-1 /CCL2 secretions as well asproliferation in human glioma cells[J].BiochimBiophys Acta,2015,1852 (1):120-130.DOI:10.1016/j.bbadis.2014.10.014.

21.KARMAKAR M,KATSNELSON M A,DUBYAKG R,et al.NeutrophilP2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretionin response to ATP[J].Nat Commun,2016,7:10555.DOI:10.1038/ncomms10555.

22.HASAN D,BLANKMAN P,NIEMANG F.Purinergic signalling links mechanical breath profile and alveolarmechanics with the pro-inflammatory innate immune response causingventilation-induced lung injury[J].PurinergicSignal,2017,13(3):363-386.DOI:10.1007/s11302-017-9564-5.

23.CHEN Y,BAO Y,ZHANG J,et al.Inhibition of neutrophils by hypertonic saline involvesPannexin-1,CD39,CD73,andother ectonucleotidases[J].Shock,2015,44(3):221-227.DOI:10.1097/SHK.0000000000000402.

24.DI VIRGILIO F,VUERICH M. Purinergicsignaling in the immune system[J].AutonNeurosci,2015,191:117-123.DOI:10.1016/j.autneu.2015.04.011.

25.BORSELLINO G,KLEINEWIETFELD M,MITRI DD,et al.Expressionof ectonucleotidase CD39 by Foxp3+ Treg cells:hydrolysisof extracellular ATP and immune suppression[J].Blood,2007,110(4):1225-1232.DOI:10.1182/blood-2006-12-064527.